vimarsana.com
Home
Live Updates
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript : comparemela.com
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
Related Keywords
United States ,
Kansas ,
Japan ,
Japanese ,
Yaron Werber ,
Anthony Pagano ,
Tahi Ahmadi ,
Asthika Goonewardene ,
James Gordon ,
Sachin Jain ,
Judith Klimovsky ,
Vikram Purohit ,
Etzer Dament ,
Anthony Mancini ,
Pfizer ,
Anthony ,
Call Transcript May ,
Genmab First Quarter ,
Investor Relations ,
Chief Operating Officer ,
Chief Medical Officer ,
Chief Development Officer ,
Annual Meeting ,
Japanese Society ,
Medical Oncology ,
Japan New Drug Application ,
Most Money ,
Thanks Vikram ,
Xian Deng ,
Thanks Judith ,
comparemela.com © 2020. All Rights Reserved.